Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Stock Price Up 4.3% – Still a Buy?

Shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) traded up 4.3% on Thursday . The stock traded as high as $18.43 and last traded at $18.46. 16,741 shares changed hands during mid-day trading, a decline of 33% from the average session volume of 25,053 shares. The stock had previously closed at $17.70.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on TLX shares. William Blair raised shares of Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research note on Tuesday, November 19th. UBS Group upped their price target on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a “buy” rating in a research report on Monday, January 27th.

Telix Pharmaceuticals Limited American Depositary Shares Price Performance

The company has a 50 day simple moving average of $17.28.

About Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.